Novel Properties of Tyrosine-mutant AAV2 Vectors in the Mouse Retina
Open Access
- 1 February 2011
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 19 (2), 293-301
- https://doi.org/10.1038/mt.2010.234
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- High-efficiency Transduction and Correction of Murine Hemophilia B Using AAV2 Vectors Devoid of Multiple Surface-exposed TyrosinesMolecular Therapy, 2010
- rAAV2/5 gene-targeting to rods:dose-dependent efficiency and complications associated with different promotersGene Therapy, 2010
- Molecular Evolution of Adeno-associated Virus for Enhanced Glial Gene DeliveryMolecular Therapy, 2009
- Inner Limiting Membrane Barriers to AAV-mediated Retinal Transduction From the VitreousMolecular Therapy, 2009
- High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype VectorsMolecular Therapy, 2009
- Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expressionVirology, 2008
- Safety and Efficacy of Gene Transfer for Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Effect of Gene Therapy on Visual Function in Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Interpretation of electron density with stereographic roadmap projectionsJournal of Structural Biology, 2006
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999